Justin Hwang received his undergraduate degree from Carnegie Mellon University in chemical engineering and went on to pursue a graduate degree in biochemistry from Tufts University. He completed his final training in 2020 at the Dana Farber Cancer Institute, Broad Institute of MIT and Harvard. During this time, he developed genome-scale functional and analytical approaches to identify gene targets in lethal cancers, including metastatic prostate cancers and breast cancer. He is currently an assistant professor at the University of Minnesota Division of Hematology, Oncology, and Transplantations. 

At the UMN, he leads collaborations and consortium studies with cancer centers such as Dana Farber Cancer Institute, John Hopkins University, National Cancer Institute, the Masonic Cancer Center (MCC), and industry partners such as Caris Precision Oncology Alliance, Decipher (veracyte), Tempus, and Foundation Medicine.